During the eight years to 320 million allocated to boost development in biological drugs.
”There is a great potential”, according to Vinnova that hold in the betting.
A company wants to develop the magnetic separation to purify the antibodies.
A university is to go ahead with a treatment of multi-drug resistant bacteria.
There are two of eleven projects were selected out of 40 who were looking for when Vinnova and the Swedish research council made a public announcement about the biological drugs last year.
The next few years there will be new rounds.